143 related articles for article (PubMed ID: 32275186)
1. Contralateral Eye Involvement and Retinal Detachment in Patients with Cytomegalovirus Retinitis Treated with Intravitreous Ganciclovir.
Ausayakhun S; Lu LJ; Ausayakuhn S; Nanegrungsunk O; Apivatthakakul A; Luewattananont D; Photcharapongsakul C; Liu Y; Holland GN; Margolis TP; Heiden D; Keenan JD
Ocul Immunol Inflamm; 2021 Aug; 29(6):1145-1150. PubMed ID: 32275186
[No Abstract] [Full Text] [Related]
2. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
3. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
[TBL] [Abstract][Full Text] [Related]
4. [Intravitreal injection of ganciclovir in AIDS patients with cytomegalovirus retinitis].
Fujino Y; Nagata Y; Miyoshi M; Ono A; Oka S; Iwamoto A; Kimura S; Mochizuki M
Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):634-40. PubMed ID: 8810241
[TBL] [Abstract][Full Text] [Related]
5. Incidence Rate and Risk Factors for Contralateral Eye Involvement among Patients with AIDS and Cytomegalovirus Retinitis Treated with Local Therapy.
Sittivarakul W; Benjhawaleemas T; Aui-Aree N; Jirarattanasopa P; Liabsuetrakul T
Ocul Immunol Inflamm; 2016 Oct; 24(5):530-6. PubMed ID: 26327465
[TBL] [Abstract][Full Text] [Related]
6. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.
Kempen JH; Jabs DA; Dunn JP; West SK; Tonascia J
Arch Ophthalmol; 2001 Jan; 119(1):33-40. PubMed ID: 11146724
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant.
Oktavec KC; Nolan K; Brown DM; Dunn JP; Livingston AG; Thorne JE
Am J Ophthalmol; 2012 Apr; 153(4):728-33, 733.e1-2. PubMed ID: 22265144
[TBL] [Abstract][Full Text] [Related]
8. High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis.
Young S; Morlet N; Besen G; Wiley CA; Jones P; Gold J; Li Y; Freeman WR; Coroneo MT
Ophthalmology; 1998 Aug; 105(8):1404-10. PubMed ID: 9709750
[TBL] [Abstract][Full Text] [Related]
9. Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis.
Guembel HO; Krieglsteiner S; Rosenkranz C; Hattenbach LO; Koch FH; Ohrloff C
Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):824-9. PubMed ID: 10502057
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen.
Teoh SC; Ou X; Lim TH
Ophthalmology; 2012 Mar; 119(3):588-95. PubMed ID: 22137552
[TBL] [Abstract][Full Text] [Related]
11. Retinal detachment in cytomegalovirus retinitis: intravenous versus intravitreal therapy.
Young S; McCluskey P; Minassian DC; Joblin P; Jones C; Coroneo MT; Lightman S
Clin Exp Ophthalmol; 2003 Apr; 31(2):96-102. PubMed ID: 12648040
[TBL] [Abstract][Full Text] [Related]
12. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.
Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
Ophthalmology; 2004 Dec; 111(12):2232-9. PubMed ID: 15582079
[TBL] [Abstract][Full Text] [Related]
13. Outcome of cytomegalovirus retinitis in immunocompromised patients without Human Immunodeficiency Virus treated with intravitreal ganciclovir injection.
Agarwal A; Kumari N; Trehan A; Khadwal A; Dogra MR; Gupta V; Sharma A; Gupta A; Singh R
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1393-401. PubMed ID: 24557658
[TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.
Jabs DA; Ahuja A; Van Natta M; Dunn JP; Yeh S;
Ophthalmology; 2013 Jun; 120(6):1262-70. PubMed ID: 23419804
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir.
Baudouin C; Chassain C; Caujolle C; Gastaud P
Ophthalmologica; 1996; 210(6):329-35. PubMed ID: 8887389
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of cytomegalovirus retinitis following the use of ganciclovir implants.
McCluskey PJ; Shah R; Versace P
Aust N Z J Ophthalmol; 1998 Aug; 26(3):207-10. PubMed ID: 9717750
[TBL] [Abstract][Full Text] [Related]
17. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis.
Freeman WR; Friedberg DN; Berry C; Quiceno JI; Behette M; Fullerton SC; Munguia D
Am J Ophthalmol; 1993 Dec; 116(6):713-20. PubMed ID: 8250074
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS.
Montero MC; Pastor M; Buenestado C; Lluch A; Atienza M
Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547
[TBL] [Abstract][Full Text] [Related]
20. [Local therapy in treatment of cytomegalovirus (CMV) retinitis in AIDS. The ganciclovir implant (pellet)].
Fuchs AV; Schneider A; Schweykart N; Klauss V; Kampik A
Ophthalmologe; 1997 Oct; 94(10):719-23. PubMed ID: 9432240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
